Adam H. Schechter
2012 - Merck & Co.
Compensation breakdown
Change in Pension Value and Nonqualified Deferred Compensation Earnings | $2,115,949 |
---|---|
Non-Equity Incentive Plan | $1,254,248 |
Option Awards | $1,519,998 |
Salary | $938,886 |
Stock Awards | $1,858,845 |
Other | $42,977 |
Total | $7,730,903 |
Schechter received $2.1M of change in pension value and nonqualified deferred compensation earnings, accounting for 27% of the total pay in 2012.
Schechter also received $1.3M in non-equity incentive plan, $1.5M in option awards, $938.9K in salary, $1.9M in stock awards and $43K in other compensation.
Rankings
In 2012, Adam H. Schechter's compensation ranked 654th out of 11,487 executives tracked by ExecPay. In other words, Schechter earned more than 94.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 654 | 94th |
Manufacturing | 239 | 94th |
Chemicals And Allied Products | 53 | 96th |
Drugs | 28 | 97th |
Pharmaceutical Preparations | 25 | 96th |
Schechter's colleagues
We found five more compensation records of executives who worked with Adam H. Schechter at Merck & Co. in 2012.
2012
Kenneth Frazier
Merck & Co.
Chief Executive Officer
2012
Peter Kim
Merck & Co.
Executive Vice President and President, Merck Research Laboratories
2012
Peter Kellogg
Merck & Co.
Chief Financial Officer
2012
Richard Bowles
Merck & Co.
Executive Vice President and Chief Ethics & Compliance Officer
2012
Bruce Kuhlik
Merck & Co.
General Counsel
News
March 31, 2022
April 2, 2021
April 1, 2020
April 8, 2019